| ARCHETYPE ID | openEHR-EHR-CLUSTER.tnm_staging-melanoma.v1 |
|---|
| Concept | TNM staging - Melanoma of skin (Sixth edition) |
|---|
| Description | TNM Staging classification for melanoma of skin (Sixth edition). |
|---|
| Use | Use only for the Sixth edition of TNM melanoma of skin classification. |
|---|
| Misuse | Not to be used for other editions of TNM classification. |
|---|
| Purpose | To record the TNM staging classification for melanoma of skin (Sixth Edition). |
|---|
| References | American Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ]
Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html
Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
|
|---|
| Copyright | copyright (c) 2009 openEHR Foundation |
|---|
| Authors | Author name: Dr Ian McNicoll
Organisation: Ocean Informatics Scotland
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
|
|---|
| Other Details Language | Author name: Dr Ian McNicoll
Organisation: Ocean Informatics Scotland
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
|
|---|
| Other Details (Language Independent) | - References: American Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ]
Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html
Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
- MD5-CAM-1.0.1: 77DA0DB2120ED76F3EF208EF4AC1468E
|
|---|
| Keywords | tumour, TNM, malignancy, cancer, staging, classification, grade, grading, stage, lymph node, metastasis, melanoma |
|---|
| Lifecycle | AuthorDraft |
|---|
| Language used | en |
|---|
| Citeable Identifier | 1013.1.526 |
|---|
| items | |
|---|
| Clinical (cTNM) | Clinical (cTNM): Clinical TNM pre-treatment classification based on physical examination, imaging and biopsies. |
|---|
| Primary tumour (T) | Primary tumour (T): Clincal assessment of the primary tumour. |
|---|
| Regional lymph nodes (N) | Regional lymph nodes (N): Clinical assessment of the regional lymph nodes.
- at0.58::NX [Regional lymph nodes cannot be assessed.
]
- at0.59::N0 [No regional lymph node metastasis.
]
- at0.60::N1 [Metastasis in one regional lymph node.
]
- at0.61::N1a [Only microscopic metastasis (clinically occult).
]
- at0.62::N1b [Macroscopic metastasis (clinically apparent).
]
- at0.63::N2 [Metastasis in two or three regional lymph nodes or intralymphatic regional metastasis.
]
- at0.64::N2a [Only microscopic nodal metastasis.
]
- at0.65::N2b [Macroscopic nodal metastasis.
]
- at0.66::N2c [Satellite or in-transit metastasis without regional nodal metastasis.
]
- at0.67::N3 [Metastasis in four or more regional lymph nodes, or matted metastatic regional lymph nodes, or satellite or in-transit metastasis with metastasis in regional lymph node(s).
]
|
|---|
| Distant metastasis (M) | Distant metastasis (M): Clinical assessment of distant metastasis.
- at0.78::MX [Distant metastasis cannot be assessed.
]
- at0.79::M0 [No distant metastasis.
]
- at0.80::M1 [Distant metastasis.
]
- at0.81::M1a [Metastasis to skin, subcutaneous tissue or lymph node(s) beyond the regional lymph nodes.
]
- at0.82::M1b [Metastasis to lung.
]
- at0.83::M1c [Metastasis to other sites, or any site with elevated serum lactic dehydrogenase (LDH).
]
|
|---|
| Residual tumour (R) | Residual tumour (R): Clinical assessment of post-treatment residual tumour.
- at0026::RX [Presence of residual tumour cannot be assessed.]
- at0027::R0 [No residual tumour.]
- at0028::R1 [Microscopic residual tumour.]
- at0029::R2 [Macroscopic residual tumour.]
|
|---|
| Clinical staging | Clinical staging: The overall Clinical staging derived from each T, N and M component e.g T1aM0NX. May include additional TNM descriptors.
- at0.90::Stage 0 [pTis,N0,M0]
- at0.91::Stage I [pT1,N0,M0]
- at0.92::Stage 1A [pT1a,N0,M0]
- at0.93::Stage IIA [pT1b,N0,M0; pT2a,N0,M0]
- at0.94::Stage IIA [pT2b,N0,M0; pT3a,N0,M0]
- at0.95::Stage IIB [pT3b,N0,M0; pT4a,N0,M0]
- at0.96::Stage IIC [pT4b,N0,M0]
- at0.97::Stage III [Any pT,N1-3]
- at0.98::Stage IIIA [pT1a-pT4a, N1a,N1b, M0]
- at0.99::Stage IIIB [pT1a-pT4a,N1b,N2b,N2c,M0; pT1a-4b,N1a,N2a,N2c,M0]
- at0.100::Stage IIIC [pT1b-pT4b,N1b,N2b,M0; Any pT,Any N,M0]
- at0.101::Stage IV [Any PT, Any N, M1]
|
|---|
| Clinical stage grouping | Clinical stage grouping: The TNM Clinical stage grouping. |
|---|
| Comment | Comment: A text comment on the Clinical staging. |
|---|
| Pathological (pTNM) | Pathological (pTNM): Pathological staging. Based on the clinical staging, results of procedures and pathological/histo-pathological assessment. |
|---|
| Primary tumour (pT) | Primary tumour (pT): Pathological assessment of the primary tumour.
- at0.43::pTX [Primary tumour cannot be assessed.
]
- at0.44::pT0 [No evidence of primary tumour.
]
- at0.45::pTis [Melanoma in situ (Clark level I) (atypical melanocytic hyperplasia, severe melanocytic dysplasia, not an invasive malignant lesion).
]
- at0.46::pT1 [Tumour 1 mm or less in thickness.
]
- at0.47::pT3 [Clark level II or III, without ulceration.
]
- at0.48::pT1b [Clark level IV or V, or with ulceration.
]
- at0.49::pT2 [Tumour more than 1 mm but not more than 2 mm in thickness.
]
- at0.50::pT2a [ Tumour more than 1 mm but not more than 2 mm in thickness, without ulceration.
]
- at0.51::pT2b [ Tumour more than 1 mm but not more than 2 mm in thickness, with ulceration.
]
- at0.52::pT3 [Tumour more than 2 mm but not more than 4 mm in thickness.
]
- at0.53::pT3a [Tumour more than 2 mm but not more than 4 mm in thickness, without ulceration.
]
- at0.54::pT3b [Tumour more than 2 mm but not more than 4 mm in thickness with ulceration.
]
- at0.55::pT4 [Tumour more than 4 mm in thickness.
]
- at0.56::pT4a [Tumour more than 4 mm in thickness, without ulceration.
]
- at0.57::pT4b [Tumour more than 4 mm in thickness, with ulceration.
]
|
|---|
| Regional lymph node (pN) | Regional lymph node (pN): Pathological assessment of the regional lymph nodes.
- at0.68::NX [Regional lymph nodes cannot be assessed.
]
- at0.69::N0 [No regional lymph node metastasis.
]
- at0.70::N1 [Metastasis in one regional lymph node.
]
- at0.71::N1a [Only microscopic metastasis (clinically occult).
]
- at0.72::N1b [Macroscopic metastasis (clinically apparent).
]
- at0.73::N2 [Metastasis in two or three regional lymph nodes or intralymphatic regional metastasis.
]
- at0.74::N2a [Only microscopic nodal metastasis.
]
- at0.75::N2b [Macroscopic nodal metastasis.
]
- at0.76::N2c [Satellite or in-transit metastasis without regional nodal metastasis.
]
- at0.77::N3 [Metastasis in four or more regional lymph nodes, or matted metastatic regional lymph nodes, or satellite or in-transit metastasis with metastasis in regional lymph node(s).
]
|
|---|
| Distant metastasis (pM) | Distant metastasis (pM): Pathological assessment of distant metastases.
- at0.84::pMX [Distant metastasis cannot be assessed.
]
- at0.85::pM0 [No distant metastasis.
]
- at0.86::pM1 [Distant metastasis.
]
- at0.87::pM1a [Metastasis to skin, subcutaneous tissue or lymph node(s) beyond the regional lymph nodes.
]
- at0.88::pM1b [Metastasis to lung.
]
- at0.89::pM1c [Metastasis to other sites, or any site with elevated serum lactic dehydrogenase (LDH).
]
|
|---|
| Residual tumour (pR) | Residual tumour (pR): Pathological assessment of post-treatment residual tumour. |
|---|
| Histopathological grading (G) | Histopathological grading (G): TNM histopathological grading classification.
- at0038::GX [Grade of differentiation cannot be assessed.]
- at0039::G1 [Well differentiated.]
- at0040::G2 [Moderately differentiated.]
- at0041::G3 [Poorly differentiated.]
- at0042::G4 [Undifferentiated.]
|
|---|
| Pathological staging | Pathological staging: The overall Pathological staging derived from each pT, pN and pM component. May include additional TNM descriptors. |
|---|
| Pathological stage grouping | Pathological stage grouping: The TNM Pathological stage grouping. |
|---|
| Comment | Comment: A text comment on the Pathological staging. |
|---|
| Other contributors | Heather Leslie Ocean Informatics Australia
Sam Heard Ocean Informatics Australia
Koray Atalag, University of Auckland, New Zealand |
|---|
| Translators | |
|---|